GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Rekvina Laboratories Ltd

Rekvina Laboratories Appoints Subrata Samanta as CFO

MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 07 Oct 2026, 07:32 PM IST  ·  BSE ID: 639169e4-896d-4389-be72-8cc43c98724a
View Original BSE Filing (PDF)
💡
In Simple Terms
Rekvina Laboratories has hired a new Chief Financial Officer, Mr. Subrata Samanta, to lead its finance department starting October 7, 2026.
🤖 AI Summary
  • Rekvina Laboratories appointed Mr. Subrata Samanta as Chief Financial Officer (CFO) and KMP.
  • The appointment is effective from October 7, 2026.
  • Mr. Samanta has over 20 years of experience in finance, costing, and taxation.
  • He has previously worked with companies including Lupin Pharmaceuticals and Glenmark Pharmaceuticals.
🏢 How This Affects the Company
⚙️
Operational Impact
The appointment of a new CFO with extensive experience in financial planning and MIS is expected to strengthen the company's financial management.
⚠️
Risk Impact
Ensures compliance and financial oversight by filling a key managerial position, reducing risk associated with a vacant CFO role.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this appointment.
👤
Who Is Affected
All shareholders are indirectly affected as the appointment of a CFO is crucial for financial oversight and management.
🔍
Management Signal
The appointment signals management's commitment to robust financial leadership and operational stability.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Subsequent board meeting minutes confirming appointment details.
Future financial reports to reflect CFO's strategic inputs.
Updates on any specific financial initiatives led by the new CFO.
LOW RISK Appointment of an experienced CFO addresses a key managerial position, mitigating associated risks.
💡 Investor Takeaway
Rekvina Laboratories Limited appointed Mr. Subrata Samanta as Chief Financial Officer, effective October 7, 2026, bringing over 20 years of finance and costing experience.
❓ Frequently Asked Questions
Who has Rekvina Laboratories appointed as its Chief Financial Officer?
Rekvina Laboratories has appointed Mr. Subrata Samanta as its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP).
When is Mr. Subrata Samanta's appointment as CFO effective?
Mr. Subrata Samanta's appointment as CFO is effective from October 7, 2026.
What is Mr. Subrata Samanta's experience?
Mr. Subrata Samanta has over 20 years of experience in Accounting, Finance, Costing, Budgeting, MIS, Taxation, Cost Audit, and Financial Planning.
Has Mr. Subrata Samanta been debarred from holding the office of CFO?
Mr. Subrata Samanta has confirmed that he is not debarred from holding the office of Chief Financial Officer by any order of SEBI or other statutory authority.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.